tiprankstipranks

Mark Bodmer Insider Profile

4 Followers
Mark Bodmer, CSO, President of R&D at Evelo Biosciences, holds 25.73K shares in Evelo Biosciences (Ticker: EVLO).
tipranks
Mark Bodmer

Mark Bodmer
Evelo Biosciences (EVLO)
CSO, President of R&D

Not Ranked
Mark Bodmer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1K
100.00%
A breakdown of Mark Bodmer's holdings

Insider Roles

Evelo Biosciences
(EVLO)
CSO, President of R&D
Roles that Mark Bodmer holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Mark Bodmer

Mark Bodmer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Evelo Biosciences
Nov 08, 2023
CSO, President of R&D
Uninformative Sell
1.04K
$1.26K
Mark Bodmer has not reported any informative transactions for EVLO, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 09, 2023
Uninformative Buy
$0.00
-
$0.00
May 10, 2023
Uninformative Sell
$8.16K
-
$0.12
Jun 12, 2023
Uninformative Sell
$3.16K
-
$0.14
Aug 09, 2023
Uninformative Sell
$29.75K
-
$0.00
Nov 03, 2023
Uninformative Sell
$2.26K
-
$0.00
List of latest transactions for each holding click on a transaction to see Mark Bodmer's performance on stock

Mark Bodmer insider profile FAQ

What is the percentage of profitable transactions made by Mark Bodmer?
The percentage of profitable transactions made by Mark Bodmer is ―.
    What is the average return per transaction made by Mark Bodmer?
    The average return per transaction made by Mark Bodmer is ―.
      What stocks does Mark Bodmer hold?
      Mark Bodmer holds: EVLO stocks.
        What was Mark Bodmer’s latest transaction?
        Mark Bodmer latest transaction was an Uninformative Sell of $1.04K.
          What was Mark Bodmer's most profitable transaction?
          Mark Bodmer’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Mark Bodmer's role in Evelo Biosciences?
            Mark Bodmer's role in Evelo Biosciences is CSO, President of R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.